AVIR

Atea Pharmaceuticals is a biotech company working on oral antiviral drugs, which are pills that treat serious viral infections. Their main focus is on hepatitis C, a liver disease caused by a virus, and they are currently testing a combination of two drugs in late-stage human trials. The company also has an experimental drug in early testing for hepatitis E, another viral liver disease. They have licensed one of their drugs to a larger pharmaceutical company for further development and sale.